Related Experiment Video
Updated: Apr 25, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Mortality in patients with giant cell arteritis
Bo Baslund1, Marie Helleberg2, Mikkel Faurschou2
1Department of Infectious Disease and Rheumatology, Rigshospitalet, Copenhagen, Denmark bo.baslund@regionh.dk.
Giant cell arteritis (GCA) is linked to a slightly higher risk of death, particularly in the early and late stages after diagnosis. This increased mortality risk is mainly associated with circulatory diseases.
Area of Science:
- Rheumatology
- Epidemiology
- Public Health
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis affecting large arteries.
- Understanding the long-term mortality associated with GCA is crucial for patient management.
Purpose of the Study:
- To investigate the association between a biopsy-proven diagnosis of GCA and all-cause mortality.
- To identify specific causes of death contributing to potential increased mortality in GCA patients.
Main Methods:
- Nationwide population-based cohort study using Danish registers (1993-2011).
- Included 1787 patients with biopsy-proven GCA and a matched comparison cohort of 33,953 individuals.
- Poisson regression analysis used to calculate mortality rate ratios.
Main Results:
- A slightly increased relative risk of death was observed 0-2 years (RR 1.17) and >10 years (RR 1.22) post-GCA diagnosis.
- No increased mortality was found between 2 and 10 years after diagnosis (RR 0.96).
- Early excess mortality was primarily linked to circulatory system diseases, including aortic aneurysms.
Conclusions:
- GCA is associated with a modest increase in both early and late mortality.
- Circulatory diseases represent a significant contributor to the excess mortality observed in the early years following GCA diagnosis.
More Related Videos
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
